Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial

Lancet

Volumn 353, Issue 9155, 1999, Pages 797-801

  Lau, W Y ^a   Leung, T W T ^a,c   Ho, S K W ^a   Chan, M ^a   Machin, D ^b   Lau, J ^a   Chan, A T C ^a   Yeo, W ^a   Mok, T S K ^a   Yu, S C H ^a   Leung, N W Y ^a   Johnson, P J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b National Medical Research Council   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL; IODINE 131;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOXICITY;

EID: 0033528522     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)06475-7     Document Type: Article

References (21)

1. Ng IO, Lai EC, Fan ST, Ng MM, So MK. Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer 1995; 76: 2443-48.
2. Lee NW, Wong J, Ong GB. The surgical management of primary carcinoma of the liver. World J Surg 1982; 6: 66-75.
3. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 241: 114-17.
4. Nagao T, Inoue S, Yochimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990; 211: 28-33.
5. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas, a univariate and multivariate analysis. Cancer 1990; 65: 1104-10.
6. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumour recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
7. Okayasu I, Hatakeyama S, Yoshida T, et al. Selective and persistent deposition and gradual drainage of iodized oil, lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery. Am J Clin Pathol 1988; 90: 536-44.
8. Madsen MT, Park CH, Thakur ML. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma. J Nucl Med 1988; 29: 1038-44.
9. Yoo HS, Park CH, Lee JT, et al. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labelled lipiodol. Cancer Chemother Pharmacol 1994; 33 (suppl): S128-33.
10. 131iodine-lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 1994; 35: 1313-18.
11. Maini CL, Scelsa MG, Fiumara C, et al. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma. Clin Nucl Med 1996; 21: 221-26.
12. Raoul JL, Guyader D, Bretagne JF, et al. Prospective randomised trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 1997; 26: 1156-61.
13. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985; 56: 918-28.
14. Geller NL, Pocock SJ. Interim analyses in randomised clinical trials: ramifications and guidelines for practitioners. Biometrics 1987; 43: 213-23.
15. Leung WT, Lau WY, Ho S, et al. Reduction of local recurrence after adjuvant intra-arterial lipiodol-ioidine-131 for hepatocellular carcinoma - a planned interim analysis of a prospective randomized study. Proc Am Soc Clin Oncol 1997; 16: 988(abstr).
16. Yamamoto M, Arii S, Sugahara K, Tobe T. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma. Br J Surg 1996; 83: 336-40.
17. Takenaka K, Yoshida K, Nishizaki T, et al. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995; 169: 400-04.
18. Izumi R, Shimizu K, Iyobe T, et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20: 295-301.
19. Lai EC, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1993; 133: 183-88.
20. Muto Y, Moriwaki H, Ninomiya M, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334: 1561-67.
21. Leung NW, Tam JS, Lai JY, et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer 1992; 70: 40-44.